CloTho tells you what you can win now, what needs work first, and what to walk away from. Grants, R&D incentives, accelerators, cloud credits and investors across NA, EMEA and APAC.
Three weeks of evidence assembled, then the clause that excludes you turns up in the first paragraph.
Nobody owns the funding calendar, so the cut-off passes and you find out in December.
Equity given away for money that was sitting in a programme nobody on the team had seen.
Everyone offering to help is paid when you apply, not when you skip.
And the clause that disqualifies you was readable on day one, in the first paragraph of the rules.
Your map is a living board. Programs open and close, your company changes, and the map moves with it.
Stage, jurisdiction, founder residency, product, revenue, R&D, IP, what you've already tried. Fifteen minutes — and it's the part that makes eligibility real instead of approximate.
Every route comes back with a verdict, an amount you can plan around, the reason behind it, and a link to the official source. Four lanes, no scoring theatre.
Open a route, see its requirements and deadline, start the application without leaving CloTho. Track what's submitted, what's waiting, and what just opened.
Fifteen minutes, no documents to upload. These are the fields eligibility turns on — and the reason a generic tool gets your case wrong.
One company, one board. Every route we check, sorted into four lanes — each with a verdict, an amount you can plan around and the next concrete step.
Apply this week
Book consultation
Apply this week
Missing: consortium
Missing: filing
Signal: TRL 6
Signal: pilot #3
Skip
Ineligible
Too early
Apply this week
Start the log
Apply this week
Missing: registration
Missing: match
Signal: 3-mo retention
Signal: $1m ARR
Ineligible
Ineligible
Skip
Four questions, no email. These are the fields eligibility actually turns on — the ones a keyword search never asks about.
Where is the company incorporated?
Do the founders live where the company is registered?
What stage is the company?
Are you spending on R&D, cloud or compute?
Answer all four and we will tell you, plainly, whether this is worth your time.
Not a research report nobody reads. Four things you can put in front of your co-founder and start moving on the same day.
Every route sorted into four lanes so the order of attention is obvious before you read a single line of detail.
The applications you are not eligible for, and the ones where the cost exceeds the award — each with the sentence that ends the debate.
Cut-offs, rolling deadlines and the date preparation has to start — so a route never closes while you were busy shipping.
One concrete action per live route and the person on your team who carries it. Nothing on the board is a task without a name.
Most tools cover one. A grant database will never tell you that $150k of cloud credits is faster, larger, and closes this month.
National, regional and EU programs. Eligibility, deadlines, co-financing rules and the evidence each one expects before you write a word.
Credits and reliefs, patent box, payroll offsets. Which of your spend qualifies, and what has to be documented to survive review.
Equity terms, stage fit, geography, cohort dates — including which ones are worth applying to and which are a three-month distraction.
AWS, Azure, Google, OpenAI, NVIDIA and the rest. Often larger and far faster than a grant, and almost nobody treats them as funding.
Founder networks, university partnerships, technology transfer offices and clusters — with the actual route in, not a promise of an intro.
Angels, funds and venture debt matched to your stage and sector, plus a straight answer on whether raising now is your strongest move.
Both give you names. Neither can tell you whether your company clears the rules — which is the only part that decides anything.
I ran corporate budgets at €7.2 billion scale. I bought technologies and companies, applied for grants, negotiated with governments, and built the partnerships that changed what a business could reach.
Built by a founder, for founders.
No success fee, no percentage of what you raise, no commission from any program on the board.
Everything the board does, for one company.
A second pair of eyes on a decision you have already made on the board.
Once the board is set: writing and filing the applications, finding your consortium partner, running grant reporting, building R&D documentation or setting up the entity — flat fees, quoted per case.
Beta price, held for everyone who joins before public launch. You pay when your map is ready, not to request access.
$290 for the map during the beta — one company, everything the board does, charged when your map is ready and not before. A 60-minute working session with a funding strategist to walk through it together is an optional $150, added only if you want it. No success fee, no percentage of anything you raise, and no card charged until your map is ready.
The intake takes about fifteen minutes and the first board comes back the same day. After that it's live: when a window opens, a rule changes, or your company crosses a signal you set, the affected routes update and you're told which ones moved.
Then the board says so, and that's a real answer worth having early. Some companies are too young, too small, or in a jurisdiction with thin programs. We'd rather show you an honest four-route board than pad it out to twenty.
No. A database returns everything matching a keyword. CloTho returns a decision: which routes you qualify for today, which need work first, which to watch, and which to drop — checked against your company, not against a search term. It also covers R&D incentives, cloud credits, accelerators, communities and investors, which grant databases don't.
No, and that's deliberate. The moment we're paid on outcomes, we lose the ability to tell you to skip something. The board takes you to the door with the requirements, the deadline and the evidence list. Walking through it is yours.
No. Nobody honestly can. We guarantee the delivery — a complete, sourced, dated map of the routes open to your company — never the decision of a program, fund or agency on it.
The beta covers the US, UK, EU and EEA, including the programs that turn on founder residency and entity structure — the part that trips up every matching tool. Tell us where you're incorporated when you request access and we'll prioritise accordingly.
It builds your map and nothing else. It isn't sold, isn't shared with programs or investors, and isn't used to train anything. Delete it and your account at any time.
Ask for access and we'll open it for you.
No card, no deck, no call. One email when your access is open.